Harnessing the Membrane Translocation Properties of AB Toxins for Therapeutic Applications
Over the last few decades, proteins and peptides have become increasingly more common as FDA-approved drugs, despite their inefficient delivery due to their inability to cross the plasma membrane. In this context, bacterial two-component systems, termed AB toxins, use various protein-based membrane...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI AG
2021-01-01
|
| シリーズ: | Toxins |
| 主題: | |
| オンライン・アクセス: | https://www.mdpi.com/2072-6651/13/1/36 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|
